Selection of thrombogenetic antiphospholipid antibodies in cerebrovascular disease patients

Journal of Neurology

Volumn 250, Issue 5, 2003, Pages 593-597

  Caso, Valeria ^a   Parnetti, Lucillla ^a   Panarelli, Paolo ^a   Viola Magni, Maria Pia ^a   Gallai, Virgilio ^a   Albi, Elisabetta ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

2 glycoprotein 1; Anti phospholipid syndrome; Cardiolipin; Stroke

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN; PHOSPHOLIPID; PHOSPHOLIPID ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; STROKE; THROMBOGENESIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTIPHOSPHOLIPID; CASE-CONTROL STUDIES; CEREBROVASCULAR DISORDERS; CONFIDENCE INTERVALS; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; THROMBOSIS;

EID: 0037843413     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-003-1045-9     Document Type: Article

References (32)

1. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd (1993) Classification of subtypes of acute ischemic stroke. Definition for use in a multicenter clinical. Stroke 24:35-41
2. Ahmed E, Stegmayr B, Trifunovic J, Weinehall L, Hallmans G, Lefvert AK (2000) Anticardiolipin antibodies are not an independent risk factor for stroke: an incident case-referent study nested within the MONICA and Vasterbotten cohort project. Stroke 31:1289-1293
3. Bevers EM, Galli M, Barbui T, Zwaal RFA (1991) Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb. Haemostasis 66:629-632
4. Bousser MG (2000) Cerebral venous thrombosis: diagnosis and management. J Neurol 247(4):252-258
5. Brey RL, Abbott RD, Curb JD, Sharp DS, Ross GW, Stallworth CL, Kittner SJ (2001) Beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: The Honolulu Heart Program. Stroke 32:1701-1706
6. Carmelingo M, Casto L, Censori B, Drago G, Frigeni A, Ferraro B, Servalli, MC, Radice E, Mamoli A (1995) Anticardiolipin antibodies in acute non-hemorrhagic stroke seen within six hours after onset. Acta Neurol Scand 92:69-71
7. Caso V, Paciaroni M, Parnetti L, Cardaioli G, Biscarini L, Acciarini AE, Rubino S, Gallai V (2002) Stroke Related to Carotid Artery Dissection in a Young Patient with Takayasu Arteritis, Systemic Lupus erythematosus and Antiphospholipid Antibody Syndrome. Cerebrovasc Dis 12:67-69
8. Chakravarty KK, Byron MA, Webley M, Durkin CJ, Al-Hillawi AH, Bodley R, Wozniak J (1991) Antibodies to cardiolipin in stroke: association with mortality and functional recovery in patients without systemic lupus erythematosus. Q J Med 79:397-405
9. deGoort PG, Derksen RHWM (1995) Specificity and and clinical relevance of lupus anticoagulant. Vessels 1:22-26
10. El-Kadi HS, Keil LB, DeBari VA (1995) Analytical and clinical relationships between human IgG autoantibodies beta2 glycoprotein I and anticardiolipin antibodies. J Rheumatol 22:2233-2237
11. Exner T (1995) Diagnostic methodologies for circulating anticoagulants. Thromb Haemost 74:338-344
12. Ginsburg KS, Liang MH, Newcomer L, Goldhaber SZ, Schur PH, Hennekens CH, Stampfer MJ (1992) Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med 117:997-1002
13. Greaves M (1999) Antiphospholipid antibodies and thrombosis. Lancet 353:1348-1353
14. Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth-Young CG, Loizou S, Hughes GR (1983) Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 2:1211-1214
15. Horbach DA, van Oort E, Donders RCJM, Derkesen RH, de Groot PG (1996) Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies. Thromb Haemost 76:916-924
16. Hughes GR, HarrisNN, Gharavi AEJ (1986) The anticardiolipin syndrome. Rheumatol 13:486-489
17. Levine JS, Branch DW, Rauch J (2002) The antiphospholipid syndrome. N Engl J Med 7; 346(10):752-763
18. Levine SR, Salowich-Palm L, Sawaya KL, Perry M, Spencer HJ, Winkler HJ, Alam Z, Carey JL (1997) IgG anticardiolipin antibody titer > 40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study. Stroke 28:1660-1665
19. Luong TH, Rand JH, Wu XX, Godbold JH, Gascon-Lema M, Tuhrim S (2001) Seasonal distribution of antiphospholipid Antibodies Stroke 32:1707-1711
20. Matsuura E, Igarashi M, Igarashi Y, Katahira T, Nagae H, Ichikawa K, Triplett DA, Koike T (1995) Molecular studies on phospholipid-binding sites and cryptic epitopes appearing on beta2-glycoprotein I structure recognized by anticardiolipin antibodies. Lupus 4:13-17
21. Metz LM, Edworthy S, Mydlarsky R, Fritzler MJ (1998) The frequency of phospholipid antibodies in an unselected stroke population. Can J Neurol Sci 25:64-917
22. Montalban J, Rio J, Khamastha M, Davalos A, Codina M, Swana, GT, Calcagnotto ME, Sumalla J, Mederer S, Gil A, Hughes GR, Codina A (1994) Value of immunologic testing in stroke patients. A prospective multicenter study. Stroke 25:2412-2415
23. Muir KW, Squire JB, Alwan W, Lees KR (1994) Anticardiolipin antibodies in an unselected stroke population. Lancet 13; 344:452-456
24. Rote NS, Dostal-Johnson D, Branch WD (1990) Antiphospholipid antibodies and recurrent pregnancy loss: correlation between the activated partial thromboplastin time and antibodies against phosphatidylserine and cardiolipin. Am J Obstet Gynecol 163:575-580
25. Silvestrelli G, Corea F, Paciaroni M, Milia P, Palmerini F, Parnetti L, Gallai V (2002) The Perugia hospital based stroke registry: report of the 2nd year. Clin Exp Hypertens 24.7&8:485-491
26. Sletness KE, Smith P, Abdelnoor M, Arnesen H, Wisloff F (1992) Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke. Lancet 339:451-453
27. Tanne D, Triplett AD, Levine SL (1998) Antiphospholipid-protein antibodies and ischemic stroke. Not just cardiolipin any more. Stroke 29:1755-1758
28. The Antiphospholipid Antibodies in Stroke Study (APASS) Group (1997) Anticardiolipin antibodies and the risk of recurrent thrombo-occlusive events and death. Neurology 48:91-94
29. Toschi V, Motta A, Castelli C, Gibelli S, Cimminiello C, Molaro GL, Gibelli (1993) A Prevalence and clinical significance of antiphospholipid antibodies to noncardiolipin antigens in systemic lupus erythematosus Haemostasis 23:275-283
30. Toschi V, Motta A, Castelli C, Paracchini, ML, Zerbi D, Gibelli A (1998) High prevalence of antiphosphatidy-linositol antibodies in young patients with cerebral ischemia of undetermined cause. Stroke 29:1759-1764
31. Tuhrim S, Rand JH, Wu X, Horowitz DR, Weinberger J, Goldman ME, Goldbold JH (1999) Antiphosphatidyl serine antibodies are independently associated with ischemic stroke. Neurology 53:1523-1527
32. Turim S, Rand JH, Wu X-X, Weinberger J, Horowitz DR, Goldman ME, Godbold JH (1999) Elevated anticardiolipin antibody titer is a stroke risk factor in a multiethnic population independent of isotype or degree of positivity. Stroke 30:1561-1565